Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-09

Clinical Trial Update: Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy of Serodase 5 mg Tablet for treating inflammation after third molar surgery, with outcomes related to trismus and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serodase 5 mg Tablet (Serodase)

Snippet

Sponsor: Hayat Pharmaceutical Co. PLC | Conditions: Trismus, Swelling | Phase 4 | Status: UNKNOWN